2160 Federal Register / Vol. 83, No. 10 / Tuesday, January 16, 2018 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Interagency 

Committee on Smoking and Health 

(ICSH) 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

ICSH. The ICSH consists of 5 experts in 

fields that represent private entities 

involved in informing the public about 

the health effects of smoking. 

Nominations are being sought for 

individuals who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the committee’s 

objectives. Nominees will be selected 

based on expertise in the fields of the 

health effects of smoking. Additionally, 

desirable qualifications include: (1) 

Knowledge of the intersection of 

behavioral health conditions (mental 

and/or substance use disorders) and 

tobacco use/tobacco control; and/or (2) 

familiarity and expertise in developing 

or contributing to the development of 

policies and/or programs for reducing 

health disparities in tobacco use in the 

United States; and/or (3) knowledge of 

emerging tobacco control policies and 

experience in analyzing, evaluating, and 

interpreting Federal, State and/or local 

health or regulatory policy. Federal 

employees will not be considered for 

membership. Members may be invited 

to serve for four-year terms. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ICSH 

objectives https://www.cdc.gov/tobacco/ 

about/icsh/index.htm. 

DATES: Nominations for membership on 

the ICSH must be received no later than 

February 28, 2018. Packages received 

after this time will not be considered for 

the current membership cycle. 

ADDRESSES: All nominations should be 

mailed to Monica Swann, Office on 

Smoking and Health, National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), CDC, 

395 E. Street SW, Room 9167, 

Washington, DC 20024, emailed 

(recommended) to mswann@cdc.gov, or 

faxed to (202) 245–0554. 

FOR FURTHER INFORMATION CONTACT: 

Simon McNabb, Designated Federal 

Official (DFO), ICSH, Office on Smoking 

and Health, NCCDPHP, CDC, 395 E. 

Street SW, Room 9167, Washington, DC 

20024, telephone (202) 245–0550; 

GMcNabb@cdc.gov. 

SUPPLEMENTARY INFORMATION: The U.S. 

Department of Health and Human 

Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented, and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens, 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees, requiring the filing of 

financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for ICSH membership each year, and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in July 2018, or as 

soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. 

Nominees must be U.S. citizens, and 

cannot be full-time employees of the 

U.S. Government. Candidates should 

submit the following items: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. 

(Candidates may submit letter(s) from 

current HHS employees if they wish, 

but at least one letter must be submitted 

by a person not employed by an HHS 

agency (e.g., CDC, NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate him- or herself, or by the 

person/organization recommending the 

candidate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–00542 Filed 1–12–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Public 

Law 92–463. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP) 

PAR 13–129, National Institute for 

Occupational Safety and Health 

(NIOSH) Member Conflict Review. 

Date: March 1, 2018. 

Time: 1:00 p.m.–4:00 p.m., EST. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Nina Turner, Ph.D., Scientific Review 

Officer, Office of Extramural Programs, 

NIOSH, CDC, 1095 Willowdale Road, 

Morgantown, West Virginia 26506, 

Telephone (304) 285–5976; nxt2@

cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 


daltland on DSKBBV9HB2PROD with NOTICES